PL2240172T3 - Kombinacja nilotynibu i chlorambucylu do leczenia przewlekłej białaczki limfocytowej - Google Patents

Kombinacja nilotynibu i chlorambucylu do leczenia przewlekłej białaczki limfocytowej

Info

Publication number
PL2240172T3
PL2240172T3 PL08864891T PL08864891T PL2240172T3 PL 2240172 T3 PL2240172 T3 PL 2240172T3 PL 08864891 T PL08864891 T PL 08864891T PL 08864891 T PL08864891 T PL 08864891T PL 2240172 T3 PL2240172 T3 PL 2240172T3
Authority
PL
Poland
Prior art keywords
nilotinib
chlorambucil
treatment
combination
lymphocytic leukemia
Prior art date
Application number
PL08864891T
Other languages
English (en)
Polish (pl)
Inventor
Raquel Silvia Aloyz
Lawrence Carl Panasci
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2240172T3 publication Critical patent/PL2240172T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08864891T 2007-12-21 2008-12-18 Kombinacja nilotynibu i chlorambucylu do leczenia przewlekłej białaczki limfocytowej PL2240172T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1570407P 2007-12-21 2007-12-21
PCT/US2008/087336 WO2009082662A1 (en) 2007-12-21 2008-12-18 Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia
EP08864891.0A EP2240172B1 (en) 2007-12-21 2008-12-18 Combination of nilotinib and chlorambucil for the treatment of chronic lymphocytic leukemia

Publications (1)

Publication Number Publication Date
PL2240172T3 true PL2240172T3 (pl) 2014-08-29

Family

ID=40352369

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08864891T PL2240172T3 (pl) 2007-12-21 2008-12-18 Kombinacja nilotynibu i chlorambucylu do leczenia przewlekłej białaczki limfocytowej

Country Status (7)

Country Link
US (2) US20110028422A1 (cg-RX-API-DMAC7.html)
EP (1) EP2240172B1 (cg-RX-API-DMAC7.html)
JP (2) JP2011507880A (cg-RX-API-DMAC7.html)
ES (1) ES2459877T3 (cg-RX-API-DMAC7.html)
PL (1) PL2240172T3 (cg-RX-API-DMAC7.html)
PT (1) PT2240172E (cg-RX-API-DMAC7.html)
WO (1) WO2009082662A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425830A1 (en) * 2010-09-03 2012-03-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Synergistic drug combination for the treatment of cancer
US20150182490A1 (en) 2012-06-26 2015-07-02 Del Mar Pharmaceuticals Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
CN105492011A (zh) 2013-04-08 2016-04-13 丹尼斯·M·布朗 不理想给药化学化合物的治疗增效
CA2941632C (en) * 2014-03-13 2023-10-24 Vasilios VOUDOURIS Bendamustine solid dispersions and continuous infusion
US9777572B2 (en) * 2014-11-17 2017-10-03 Baker Hughes Incorporated Multi-probe reservoir sampling device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3046301A (en) 1959-10-29 1962-07-24 Burroughs Wellcome Co Method of making chlorambucil
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
ATE468855T1 (de) 2002-11-12 2010-06-15 Jewish General Hospital Kombination von stickstoff-senf analogen und imatinib für die behandlung von chronischer lymphatischer leukämie
GT200600315A (es) 2005-07-20 2007-03-19 Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida

Also Published As

Publication number Publication date
JP2011507880A (ja) 2011-03-10
ES2459877T3 (es) 2014-05-12
PT2240172E (pt) 2014-05-28
JP2014177487A (ja) 2014-09-25
US20110028422A1 (en) 2011-02-03
WO2009082662A1 (en) 2009-07-02
EP2240172A1 (en) 2010-10-20
EP2240172B1 (en) 2014-03-19
US20150051236A1 (en) 2015-02-19

Similar Documents

Publication Publication Date Title
IL200565A0 (en) Inhaler
IL254218A0 (en) Pipedrine-bridged compounds of the quinoxaline-converted type and their use
ZA201007114B (en) Compositions useful for the treatment of diabetes and other chronic disorder
PT2114900T (pt) Compostos à base de tiopirimidina e as suas utilizações
ZA200909172B (en) Inhaler
EP2209511A4 (en) INHALATION DEVICE
ZA201000428B (en) Desalination
GB2449081B (en) Breathing detection
ZA200904981B (en) Cable-free arthroendoscope
PL2203205T3 (pl) Inhalator
ZA201001435B (en) Inhaler
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
AU321242S (en) Inhaler
IL205137A0 (en) 5-cyanothienopyridines for the treatment of tumours
EP2106253A4 (en) TREATMENT OF ACOUPHEN
GB0809508D0 (en) Carburettors
GB2441963B (en) Height-Adjusting Apparatus
IL201249A0 (en) 18f - labelled folates
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
PT2240172E (pt) Combinação de nilotinib e clorambucilo para o tratamento da leucemia linfocítica crónica
PL2289540T3 (pl) Alfa-1-antytrypsyna do stosowania w leczeniu zespołu chronicznego zmęczenia
GB0708392D0 (en) Breathing device
GB0700903D0 (en) Fluid treatment apparatus
IL193414A0 (en) Meridamycin analogues for the treatment ofneurodegenererative disorders
GB0708445D0 (en) Compounds and uses thereof